Organism name | Neodilsea yendoana |
---|---|
Genus | |
Family | |
Kingdom |
Linked NCBI taxonomy name | Neodilsea yendoana |
---|---|
Linked NCBI taxonomy ID | 142541 |
Linked level | species |
Family in NCBI taxonomy | Dumontiaceae |
---|---|
ID | 31415 |
Kingdom (Superkingdom) in NCBI taxonomy | Eukaryota |
---|---|
ID | 2759 |
Plant class | |
---|---|
ID |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001215
![]() |
(5Z,8Z,11Z,14Z,17Z)-Eicosapentaenoic acid
|
CHEMBL460026
|
D015118
|
12 / 12 / 10 | 36 / 17 | No. 2002 | No. 50 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001215 | 2 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00001215 | 2 / 3 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001215 | 0 / 0 |
Q9UGP5 | DNA polymerase lambda | Enzyme | C00001215 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001215 | 1 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00001215 | 0 / 0 |
P11511 | Cytochrome P450 19A1 | Cytochrome P450 19A1 | C00001215 | 2 / 2 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | C00001215 | 5 / 3 |
P13726 | Tissue factor | Membrane receptor | C00001215 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001215 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001215 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001215 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
19 | ABCA1, ABC-1, ABC1, CERP, HDLDT1, TGD | ATP-binding cassette, sub-family A (ABC1), member 1 |
C00001215
|
9619 | ABCG1, ABC8, WHITE1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
C00001215
|
9370 | ADIPOQ, ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1, GBP28 | adiponectin, C1Q and collagen domain containing |
C00001215
|
338 | APOB, FLDB, LDLCQ4 | apolipoprotein B |
C00001215
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001215
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00001215
|
958 | CD40, Bp50, CDW40, TNFRSF5, p50 | CD40 molecule, TNF receptor superfamily member 5 |
C00001215
|
1401 | CRP, PTX1 | C-reactive protein, pentraxin-related |
C00001215
|
1535 | CYBA, p22-PHOX | cytochrome b-245, alpha polypeptide |
C00001215
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001215
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001215
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00001215
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001215
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001215
|
117159 | DCD, AIDD, DCD-1, DSEP, HCAP, PIF | dermcidin |
C00001215
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00001215
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001215
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001215
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00001215
|
3558 | IL2, IL-2, TCGF, lymphokine | interleukin 2 |
C00001215
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00001215
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001215
|
3952 | LEP, LEPD, OB, OBS | leptin |
C00001215
|
778733 |
C00001215
|
||
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001215
|
5467 | PPARD, FAAR, NR1C2, NUC1, NUCI, NUCII, PPARB | peroxisome proliferator-activated receptor delta |
C00001215
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00001215
|
10891 | PPARGC1A, LEM6, PGC-1(alpha), PGC-1v, PGC1, PGC1A, PPARGC1 | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
C00001215
|
5683 | PSMA2, HC3, MU, PMSA2, PSC2 | proteasome (prosome, macropain) subunit, alpha type, 2 (EC:3.4.25.1) |
C00001215
|
5693 | PSMB5, LMPX, MB1, X | proteasome (prosome, macropain) subunit, beta type, 5 (EC:3.4.25.1) |
C00001215
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00001215
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00001215
|
56729 | RETN, ADSF, FIZZ3, RETN1, RSTN, XCP1 | resistin |
C00001215
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00001215
|
6720 | SREBF1, SREBP-1c, SREBP1, bHLHd1 | sterol regulatory element binding transcription factor 1 |
C00001215
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001215
|
OMIM | preferred title | UniProt |
---|---|---|
#613546 | Aromatase deficiency |
P11511
|
#139300 | Aromatase excess syndrome; aexs |
P11511
|
%606641 | Body mass index; bmi |
P37231
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#601665 | Obesity |
P37231
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P11511
(related)
|
H00794 | Aromatase excess syndrome |
P11511
(related)
|
H00032 | Thyroid cancer |
P37231
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P37231
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000743 | Anemia, Hemolytic |
C00001215
|
D001145 | Arrhythmias, Cardiac |
C00001215
|
D002114 | Calcinosis |
C00001215
|
D002318 | Cardiovascular Diseases |
C00001215
|
D003327 | Coronary Disease |
C00001215
|
D003866 | Depressive Disorder |
C00001215
|
D050171 | Dyslipidemias |
C00001215
|
D018149 | Glucose Intolerance |
C00001215
|
D006973 | Hypertension |
C00001215
|
D015228 | Hypertriglyceridemia |
C00001215
|
D007333 | Insulin Resistance |
C00001215
|
D007414 | Intestinal Neoplasms |
C00001215
|
D048629 | Micronuclei, Chromosome-Defective |
C00001215
|
D010146 | Pain |
C00001215
|
D010300 | Parkinson Disease |
C00001215
|
D012559 | Schizophrenia |
C00001215
|
D013927 | Thrombosis |
C00001215
|